COMMUNIQUÉS West-GlobeNewswire
-
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
19/05/2026 -
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks
19/05/2026 -
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
19/05/2026 -
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
19/05/2026 -
Artiva Biotherapeutics Appoints Veteran Biotech Executive and Drug Developer Diego Miralles, M.D., as President and Head of Research and Development
19/05/2026 -
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
19/05/2026 -
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
19/05/2026 -
Matisse Pharmaceuticals receives FDA IND clearance for isupartob sodium
19/05/2026 -
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
19/05/2026 -
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
19/05/2026 -
ITM to Announce Dosimetry Data from the Phase 3 COMPETE Trial at SNMMI 2026 and Host Satellite Symposium
19/05/2026 -
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
19/05/2026 -
Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
19/05/2026 -
Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC
19/05/2026 -
Brain Cancer Canada Invests $75,000 in Groundbreaking Glioblastoma Research at University of Alberta, Targeting How Tumours “Communicate”
19/05/2026 -
Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy
19/05/2026 -
Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide
19/05/2026 -
Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function
19/05/2026 -
TRUE-See Reports New Peer-Reviewed Publication that Highlights the Critical Role of Accuracy and Quality Standards in Medical Photography
19/05/2026
Pages